VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA. (2016). Prospects in Pharmaceutical Sciences, 14(8), 52-56. https://doi.org/10.56782/pps.117